Paraneoplastic syndrome is best described as:

• A. Paraneoplastic symptoms occur when tumors secrete hormones that cause systemic effects.
• B. Paraneoplastic syndrome results from direct tumor invasion into the nervous system.
• C. The immune system produces antibodies meant to attack cancer cells that instead cross-react with and attack healthy tissues, particularly the nervous system.
• D. Paraneoplastic syndrome is caused by chemotherapy toxicity.

Answer: (C)

Paraneoplastic syndromes arise when the body’s immune response to a tumor mistakenly targets normal tissues. Often, antibodies or T cells produced against tumor antigens cross-react with antigens in the nervous system, leading to neurologic symptoms. This immune-mediated cross-reactivity best explains remote effects that aren’t due to the tumor invading the tissue itself or to the toxicity of treatment.

This is why the description focusing on antibodies meant to attack cancer cells that end up attacking healthy tissues, especially the nervous system, is the most accurate. Direct tumor invasion into the nervous system would be a direct effect of the tumor, not a paraneoplastic phenomenon. Chemotherapy toxicity is a treatment-related issue, not a paraneoplastic mechanism. While ectopic hormone production can cause systemic effects in some cancers, the defining mechanism of classic paraneoplastic syndromes is immune cross-reactivity rather than hormone secretion.